TrialBlood2019

Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results.

Amy D Shapiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.